Holy Stone Healthcare Co., Ltd. (TPEX:4194)
8.10
-0.37 (-4.37%)
Oct 8, 2026, 2:27 PM CST
Holy Stone Healthcare Market Cap
Holy Stone Healthcare has a market cap or net worth of 1.18 billion as of October 9, 2026. It is the 32,621st most valuable company in the world and the 1,965th biggest in Taiwan. Its market cap has decreased by 21.36% in one year.
Market Cap
1.18B
Enterprise Value
1.11B
Revenue
n/a
Global Rank
Country Rank
#1,965 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 13, 2013, Holy Stone Healthcare's market cap has decreased from 5.54B to 1.18B, a decrease of -78.68%. That is a compound annual growth rate of -11.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.18B | 5.19% |
| Dec 31, 2025 | 1.12B | -40.54% |
| Dec 31, 2024 | 1.89B | -21.47% |
| Dec 29, 2023 | 2.41B | -36.56% |
| Dec 30, 2022 | 3.79B | 20.29% |
| Dec 30, 2021 | 3.15B | 17.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Advagene Biopharma | 1.42B |
| Abnova (Taiwan) | 1.37B |
| NeoCore Technology | 1.24B |
| Enimmune | 1.19B |
| Bio Preventive Medicine | 1.18B |
| GeneReach Biotechnology | 1.13B |
| LabTurbo Biotech | 1.11B |
| BiOptic | 1.03B |